MMP2 and cardiac hypertrophy: Rizzi et al. [13] demonstrated that β1 blockers—nebivolol and metoprolol—exerted antioxidant effects, reduced MMP-2 activity, and improved cardiac hypertrophy in a rat two-kidney one-clip (2K1C) hypertension model.